Offer : pcd pharma franchise , third party manufacturing
RESEBRON PLUS TABLETS
(Acebrophylline 100 mg +N-Acetylcysteine 600 mg )
Indications:
COPD
Asthma
Bronchitis
Acebrophylline:
Significantly reduces the airway inflammation and obstruction in chroic stages.
A better choice than theophylline for COPD patients having cardiovascular co-morbidity.
Significantly improves cough scoring and sputum quantity in patients with mild persistent asthma.
N-Acetylcysreine:
Facilitates the removal of pulmonary secretions & reduces the viscosity of sputum in both cystic fibrosis and COPD.
Effectively prevents the Steroid resistant acute exacerbation of Asthma.
Offers preventive effects against airways hyper-responsiveness.
